Skip to main content
Type at least 3 characters

403 articles

Original Research

Published on 04 Sep 2025

Effectiveness of infection control measures informed by a modified Blue-Carba test in reducing rectal carriage of carbapenemase-producing bacteria in general wards: a prospective interrupted time series study

in Pharmacology of Infectious Diseases

  • Maximiliano Gabriel Castro
  • Fernanda Argarañá
  • Carla Bernasconi
  • Leticia Margenet
  • Ana Paula Amato
  • Joaquín Ignacio Coduri Anthonioz Blanc
  • Erwin Alexander Rottoli
  • Manuel Protto
  • Macarena Vicino
  • María José Sadonio
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1584646
  • 896 views

Study Protocol

Published on 07 Aug 2025

Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design

in Pharmacology of Infectious Diseases

  • Mirna Momčilović
  • Ivan Šitum
  • Ante Erceg
  • Marko Siroglavić
  • Mila Lovrić
  • Laura Nižić Nodilo
  • Anita Hafner
  • Jasmina Lovrić
  • Petra Turčić
  • Dora Fabijanović
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1618987
  • 1,008 views

Systematic Review

Published on 31 Jul 2025

Exploring the clinical effects of Andrographis paniculata-derived compounds, its extract, or derivatives for the treatment of COVID-19: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

  • Peerapong Prabhakornritta
  • Neti Waranuch
  • Anjana Fuangchan
  • Kantapich Srikham
  • Kansak Boonpattharatthiti
  • Cindy Barnig
  • Siwaporn Boonyasuppayakorn
  • Tasana Pitaksuteepong
  • Parvapan Bhattarakosol
  • Brice Moulari
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1598255
  • 1,058 views